Curi RMB Capital LLC Increases Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Curi RMB Capital LLC increased its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 3.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,650 shares of the medical instruments supplier’s stock after acquiring an additional 2,614 shares during the period. Curi RMB Capital LLC’s holdings in West Pharmaceutical Services were worth $21,807,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. LGT Group Foundation acquired a new position in West Pharmaceutical Services during the 2nd quarter worth $68,854,000. Liontrust Investment Partners LLP purchased a new position in West Pharmaceutical Services in the second quarter valued at approximately $64,196,000. Iron Triangle Partners LP acquired a new stake in West Pharmaceutical Services during the 1st quarter worth $47,381,000. Sei Investments Co. increased its position in West Pharmaceutical Services by 12.7% during the second quarter. Sei Investments Co. now owns 401,026 shares of the medical instruments supplier’s stock worth $132,095,000 after buying an additional 45,208 shares during the period. Finally, Intermede Investment Partners Ltd raised its holdings in shares of West Pharmaceutical Services by 20.7% in the first quarter. Intermede Investment Partners Ltd now owns 248,073 shares of the medical instruments supplier’s stock valued at $98,165,000 after buying an additional 42,536 shares during the last quarter. Hedge funds and other institutional investors own 93.90% of the company’s stock.

Insider Buying and Selling at West Pharmaceutical Services

In related news, VP Charles Witherspoon sold 703 shares of the stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $310.40, for a total transaction of $218,211.20. Following the sale, the vice president now owns 1,253 shares of the company’s stock, valued at $388,931.20. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Price Performance

Shares of NYSE WST opened at $344.12 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.00 and a quick ratio of 2.23. The company has a market cap of $24.92 billion, a PE ratio of 51.06, a P/E/G ratio of 24.78 and a beta of 1.00. West Pharmaceutical Services, Inc. has a 1-year low of $265.00 and a 1-year high of $413.70. The stock has a fifty day moving average price of $304.87 and a 200 day moving average price of $316.60.

West Pharmaceutical Services (NYSE:WST) last issued its earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 EPS for the quarter, topping the consensus estimate of $1.50 by $0.35. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The company had revenue of $746.90 million for the quarter, compared to analyst estimates of $709.62 million. During the same period in the previous year, the firm earned $2.16 EPS. The business’s revenue was down .1% on a year-over-year basis. Sell-side analysts forecast that West Pharmaceutical Services, Inc. will post 6.66 EPS for the current year.

West Pharmaceutical Services Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 20th. Stockholders of record on Wednesday, November 13th will be paid a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 0.24%. The ex-dividend date of this dividend is Wednesday, November 13th. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.20. West Pharmaceutical Services’s payout ratio is 11.87%.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.